Manufacturing Facility

MANUFACTURING FACILITY

Cunningham Pharmaceuticals (Pvt.) Ltd has developed state of a state of the art cGMP production facility in Pakistan to ensure the production of high-quality products to cater to local and international needs. The manufacturing facility is designed by highly experienced consultants and engineers having vast experience of setting up GMP compliant manufacturing facilities for renowned local and multinational companies.

This modern production facility was designed keeping in view the principles of cGMP, efficient production control, quality assurance, industrial safety, occupational health, and environmental control systems. This is to ensure that every product bearing name of Cunningham Pharmaceuticals meets the highest international quality standards of production, safety, and efficacy.

MANUFACTURING FACILITY


  • Total Area 37,212 sq ft.
  • Total covered Area 56,309 sq ft.
  • Established in 2016
  • License No. 000840

GROUND FLOOR 2810 sq ft

  • General tablet
  • General Capsules
  • Sachet
  • QC and Microbiological Lab
  • Ware Houses (Finished Goods, Raw Material & Packing Material)

First Floor

  • Cephalosporin Capsule (772 sq ft)
  • Cephalosporin Dry Powder Suspemsion (718 sq ft)
  • Cephalosporin Dry Powder Injection (2290 sq ft)
  • General Ophthalmic Drops (1031 sq ft)
  • Steroidal Ophthalmic Drops (776 sq ft)
  • Psychotropic Liquid Injection (2575 sq ft)
  • Psychotropic Tablets (1404 sq ft)